Livzon Pharmaceutical Group Co., Ltd. (LP6)
Market Open
11 Aug, 06:03
XFRA 
€
2. 82
+0.02
+0.7143%
€
2.59B Market Cap
16.28 P/E Ratio
0.53% Div Yield
1,000 Volume
2.16 Eps
€ 2.8
Previous Close Want to track LP6 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Livzon Pharmaceutical Group Co., Ltd. (LP6) Statistics
Valuation metrics
Market Cap 2.59B
Enterprise value -422.96M
Trailing P/E (ttm) 10.36
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.22
Price/Book (mrq) 1.4
Enterprise Value/Revenue -0.29
Enterprise Value/EBITDA -1.08
Overview
Shares outstanding 887.91M
Float 460.49M
Shares short -
% Held by insiders 0.54%
% Held by institutions 0.14%
Average volume (10 days) 500
Average volume (90 days) 280
Price summary
52-Week low 2.54
52-Week high 4.3
Beta 0.28
50-Day moving average 2.97
200-Day moving average 3.29
Dividends and splits
Forward annual dividend rate 0.53
Forward annual dividend yield 0.1802%
Trailing annual dividend rate 0.13
Trailing annual dividend yield 0.0451%
5-Year annual dividend yield 5.67%
Payout ratio 0.5
Dividend Date -
Ex-Dividend Date -
Last split factor 13:10
Last split Date 3 Jul 2019
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.17%
Operating margin 0.29%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.15%
Income Statement
Revenue (ttm) 1.48B
Revenue per share (ttm) 13.15
Quarterly revenue growth (yoy) -0.1%
Gross profit (ttm) 972.74M
EBITDA 3.21B
Net income to common (ttm) 247.71M
Diluted EPS (ttm) 0.28
Quarterly earnings growth (yoy) -0.09%
Balance Sheet
Total cash (mrq) 1.26B
Total cash per share (mrq) 11.23
Total debt (mrq) 374.16M
Total Debt/Equity (mrq) 19.03
Current ratio (mrq) 1.96%
Book value per share (mrq) 2.07
Cash Flow
Cash flow statement 408.48M
Levered free cash flow (LFCF) 241.92M
